Clinical Trials Directory

Trials / Terminated

TerminatedNCT00001788

Genetic Basis of Primary Immunodeficiencies

Molecular Basis of Primary Immunodeficiencies

Status
Terminated
Phase
Study type
Observational
Enrollment
119 (actual)
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · NIH
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate patients with primary immunodeficiency disorders to identify patients with mutations of the genes for the following proteins: Jak3, STAT1, STAT4, interleukin-7, interleukin-7 receptor, interleukin-12 receptor subunits, and others. Patients will undergo screening history, physical examination, and clinical laboratory evaluation at referring institutions and tissue samples, or cell lines will be sent to the NIH. We will establish cell lines if necessary, prepare DNA and RNA for molecular genetic analysis and study cytokine signal transduction in patient cell lines.

Detailed description

The purpose of this study is to evaluate patients with primary immunodeficiency disorders to identify patients with mutations of the genes for the following proteins: Jak3, STAT1, STAT4, interleukin-7, interleukin-7 receptor, interleukin-12 receptor subunits, and others. Patients will undergo screening history, physical examination, and clinical laboratory evaluation at referring institutions and tissue samples, or cell lines will be sent to the NIH. We will establish cell lines if necessary, prepare DNA and RNA for molecular genetic analysis and study cytokine signal transduction in patient cell lines.

Conditions

Timeline

Start date
2011-08-21
Primary completion
2019-07-02
Completion
2020-07-16
First posted
1999-11-04
Last updated
2021-05-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00001788. Inclusion in this directory is not an endorsement.